2025年全球心血管和软组织修復贴片市场报告

近年来，心血管和软组织修復补片市场规模迅速扩张，从2024年的43.9亿美元成长到2025年的48.5亿美元，复合年增长率为10.5%。预测期内的成长可归因于人口老化、慢性病增加、意识提升和早期发现、医疗基础设施建设以及疝气修復需求旺盛。

心血管和软组织修復贴片市场规模预计将在未来几年快速成长，到2029年将达到73.6亿美元，年复合成长率（CAGR）为11.0%。预测期内的成长可归因于微创手术的兴起、诊断工具的改进、个人化医疗需求的不断增长以及研发的加强。预测期内的主要趋势包括技术创新、外科手术技术的进步、再生医学的进步、3D列印以及数据分析和人工智慧(AI)的应用。

心血管和软组织修復补片是由试管内培养组织和聚合物组成的实验室人工组织。这些补片旨在修復受损的身体组织，为受损的心肌提供机械再生支持，并恢復受损组织的功能特性，以治疗心血管疾病。

用于製造心血管和软组织修復补片的主要原料包括发泡聚四氟乙烯 (ePTFE)、生物材料、组织工程材料和其他相关原料。 ePTFE 是一种常用于导管和心臟缝线等医疗器材的材料，由四氟乙烯聚合物单元组成，以其生物相容性而闻名。因此，其产品包括合成补片和生物相容性补片，其应用范围从心臟修復到各种心臟相关疾病，包括心房中隔缺损、心室中隔缺损和血管修復。心血管和软组织修復补片的最终使用者包括医院、门诊手术中心和专科诊所。

2025年春季，美国关税上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供心血管和软组织修復贴片市场统计数据，包括全球市场规模、各地区市场份额、竞争对手的市场份额、详细的心血管和软组织修復贴片细分市场、市场趋势和机会，以及您在心血管和软组织修復贴片行业取得成功所需的数据。这份心血管和软组织修復贴片市场研究报告对该行业的现状和未来走势进行了详细分析，为您提供所需的一切资讯的完整观点。

未来五年预测成长率为11.0%，较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自巴西和瑞士等主要地区的牛心包组织和聚四氟乙烯 (PTFE) 增强网征收关税直接影响美国，并可能导致血管重组成本上升，并可能导致紧急心臟修復物资短缺。由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

预计对心臟病相关贴片不断增长的需求将推动心血管和软组织修復贴片市场的成长。心臟疾病包括与心臟和血管相关的各种疾病。对治疗心臟疾病的贴片不断增长的需求在很大程度上受到吸烟和饮酒等生活方式因素的影响。例如，2024 年 5 月，总部位于乔治亚的国家公共卫生组织疾病管制与预防中心 (CDC) 报告称，心臟病将导致 2022 年 702,880 人死亡，占死亡人数的五分之一。这相当于每 33 秒就有一人死于心血管疾病。在美国，每年约有 805,000 人心臟病发作，其中 605,000 人是首次心臟病发作，20 万人曾经心臟病发作。因此，预计对心臟病相关贴片不断增长的需求将在未来几年推动心血管和软组织修復贴片市场的发展。

预计政府在医疗保健研究和开发方面的倡议将进一步推动心血管和软组织修復贴片市场的成长。政府当局积极参与实施计划、政策和计划，以应对医疗保健挑战、实现具体目标并促进社会积极变化。 2022 年，英国政府透过卫生和社会保障部宣布投资 2.6 亿英镑（2.7065 亿美国）加强医疗保健研究和製造。这项承诺旨在透过引入隐私保护平台和临床研究服务来支持 NHS主导的健康研究。此外，还拨款 6,000 万英镑（6,360 万美国）用于促进英国生命科学製造业的扩张。因此，政府在医疗保健研究和开发方面的倡议在推动心血管和软组织修復贴片市场方面发挥关键作用。

心血管和软组织修復贴片市场的一个主要趋势是技术进步的融合。该领域的公司正在积极开发创新产品和技术，以满足日益增长的市场需求。 2022年10月，印度医疗科技公司Dozee推出了一款基于人工智慧的心电图贴片，用于远端心臟监测。这款心电图贴片设计紧凑、灵活、轻便，为医生接收远端警报和存取患者即时、连续的心电图数据提供了便捷的解决方案。这些技术进步的整合正在促进整个心血管和软组织修復贴片市场的成长和重要性。

心血管和软组织修復贴片市场的主要企业正在积极开发一次性心臟贴片等创新产品，推动市场收益。一次性心臟贴片是一种黏性医疗设备，设计用于直接贴在心臟上，提供机械支撑并减少心肌拉伸。 2022 年 10 月，美国着名医疗设备公司 Mawi 推出了 Mawi 心臟贴片，这是一款一次性双导极心臟监视器，可即时追踪心臟健康状况。这款创新贴片可在诊所或家中灵活使用，患者可配戴长达七天。 Mawi 心臟贴片代表了心臟监护技术的重大进步，有可能改善患者的预后并挽救生命。

2024年6月，美国医疗设备製造商史赛克（Stryker）收购了Artelon，收购金额未揭露。此次收购旨在扩大公司在关节保护和软组织重组的产品系列。 Artelon专注于开发用于软组织加固和修復的创新生医材料，尤其在运动医学和肢体手术领域。 Artelon总部位于乔治亚，专注于医疗设备製造。

心血管和软组织修復贴片市场的主要企业包括 B Braun、Baxter International Inc.、CorMatrix Cardiovascular Inc.、Cryolife Inc.、Edwards Lifesciences Corporation、LeMaitre Vascular Inc.、Anteris Technologies Limited、Abbott Laboratories、Terumo Medical Corporation、Integra Life Corporation、Anteris Technologies Limited、Abbott Laboratories、Terumo Medical Corporation、Integra Life Corporation、Sciences Inc.L.S. Corporation、Medtronic Inc、ACell Inc.、Tissue Regenix Group Plc、Aroa Biosurgery Ltd.、Zimmer Biomet、LifeNet Health Inc.、Becton Dickinson and Company、Boston Scientific Corporation、Cook Medical、Endologix Inc.、Getinge AB、Vascular Solutions Inc.、AngioDynamics Inc.、Sampillan. Surgical Inc.、Admedus Ltd.、LabCor Corp.、Smith &Nephew plc 和 Organogenesis Inc.

2024年，北美是心血管和软组织修復贴片市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。心血管和软组织修復贴片市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

心血管和软组织修復贴片市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

心血管和软组织修復补片市场包括异种移植补片和同种异体移植补片的销售。该市场的价值是指“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球心血管和软组织修復贴片：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球心血管和软组织修復贴片市场：成长率分析
• 全球心血管与软组织修復贴片市场表现：规模与成长，2019-2024
• 全球心血管与软组织修復贴片市场预测：规模与成长，2024-2029年，2034年
• 全球心血管和软组织修復补片：总目标市场（TAM）

第六章 市场细分

• 全球心血管和软组织修復贴片市场（按材料、性能和预测），2019-2024 年、2024-2029 年、2034 年
• ePTFE
• 生物材料与组织工程材料
• 其他成分
• 全球心血管和软组织修復贴片市场：按产品、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 合成补片
• 生物补丁
• 全球心血管和软组织修復贴片市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 心臟修復
• 心房中膈缺损症
• 共享中庭
• 心内膜垫缺损
• 室间隔缺损
• 法洛氏四合症
• 右心室流出道重组
• 缝合出血
• 血管修復与重组
• 大血管转位
• 全球心血管和软组织修復贴片市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 门诊手术中心
• 专科诊所
• 全球心血管和软组织修復贴片市场：按膨体聚四氟乙烯 (ePTFE) 细分，类型，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 不可吸收ePTFE贴片
• 可吸收ePTFE贴片
• 全球心血管和软组织修復贴片市场：按生物材料和组织工程材料细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 胶原蛋白蛋白贴片
• 合成聚合物贴片（例如聚丙烯、聚氨酯）
• 去细胞组织补片
• 全球心血管及软组织修復贴片市场：依其他原料细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 硅酮
• 水凝胶基材料
• 天然材质

第七章 区域和国家分析

• 全球心血管和软组织修復贴片市场：区域分析、预测和成长，2019-2024 年、2024-2029 年、2034 年
• 全球心血管及软组织修復贴片市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 心血管和软组织修復贴片市场：竞争格局
• 心血管和软组织修復贴片市场：公司简介
  • B Braun Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • CorMatrix Cardiovascular Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Cryolife Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• LeMaitre Vascular Inc.
• Anteris Technologies Limited
• Abbott Laboratories
• Terumo Medical Corporation
• Integra LifeSciences Corporation
• WL Gore & Associates Inc.
• Arthrex Inc.
• Johnson & Johnson
• Stryker Corporation
• LifeCell Corporation
• Medtronic Inc.
• ACell Inc.
• Tissue Regenix Group Plc
• Aroa Biosurgery Ltd.
• Zimmer Biomet

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年心血管和软组织修復贴片市场：提供新机会的国家
• 2029年心血管与软组织修復贴片市场：细分市场带来新机会
• 2029年心血管和软组织修復贴片市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Cardiovascular and soft tissue repair patches are artificial tissues created in the laboratory, composed of tissues grown in vitro and polymers. These patches serve the purpose of restoring damaged body tissues, providing mechanical regeneration support for injured myocardium layers, and reinstating the functional characteristics of damaged tissues for the treatment of cardiovascular diseases.

The primary raw materials used in the production of cardiovascular and soft tissue repair patches include ePTFE (expanded Polytetrafluoroethylene), biomaterial and tissue-engineered material, and other relevant raw materials. ePTFE, a material commonly used in medical devices like catheters and cardiac sutures, is composed of tetrafluoroethylene polymer units and is known for its biocompatible properties. The resulting products include synthetic patches and biological patches, with applications ranging from cardiac repair to various heart-related conditions such as atrial septal defect, ventricular septal defect, and vascular repair. The end users of cardiovascular and soft tissue repair patches encompass hospitals, ambulatory surgical centers, and specialty clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The cardiovascular and soft tissue repair patches market research report is one of a series of new reports from The Business Research Company that provides cardiovascular and soft tissue repair patches market statistics, including cardiovascular and soft tissue repair patches industry global market size, regional shares, competitors with a cardiovascular and soft tissue repair patches market share, detailed cardiovascular and soft tissue repair patches market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular and soft tissue repair patches industry. This cardiovascular and soft tissue repair patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular and soft tissue repair patches market size has grown rapidly in recent years. It will grow from $4.39 billion in 2024 to $4.85 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to aging population, rise in chronic diseases, awareness and early detection, healthcare infrastructure growth, and high demand for hernia repairs.

The cardiovascular and soft tissue repair patches market size is expected to see rapid growth in the next few years. It will grow to $7.36 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to minimally invasive procedures, enhanced diagnostic tools, increasing demand for personalized medicine, and increasing research and development. Major trends in the forecast period include technological innovations, advancements in surgical techniques, advancements in regenerative medicine, 3D printing, the use of data analytics and artificial intelligence (ai).

The forecast of 11.0% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on bovine pericardium tissue and polytetrafluoroethylene (PTFE) reinforcement meshes, sourced from key regions such as Brazil and Switzerland, which could lead to higher costs for vascular reconstructions and potential shortages in emergency cardiac repairs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for patches related to cardiac disease is projected to drive the growth of the cardiovascular and soft tissue repair patches market. Cardiac disease encompasses a range of disorders associated with the heart and blood vessels. The rising need for patches addressing cardiac conditions is largely influenced by lifestyle factors, including smoking and alcohol consumption. For instance, in May 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in Georgia, reported that in 2022, heart disease led to 702,880 deaths, accounting for 1 in every 5 fatalities. This equates to one individual succumbing to cardiovascular disease every 33 seconds. Each year, about 805,000 people in the United States suffer a heart attack, of which 605,000 are experiencing their first heart attack, while 200,000 have had a previous heart attack. Thus, the increasing demand for patches related to cardiac disease is expected to drive the cardiovascular and soft tissue repair patches market in the coming years.

Anticipated growth in the cardiovascular and soft tissue repair patches market is further propelled by government initiatives focused on research and development in healthcare. Government authorities are actively involved in implementing programs, policies, and projects to address healthcare challenges, achieve specific goals, and foster positive societal changes. In 2022, the UK government, through the Department of Health and Social Care, announced a substantial investment of £260 million (US $270.65 million) to boost healthcare research and manufacturing. This commitment aims to support NHS-led health research by introducing privacy-preserving platforms and clinical research services. Additionally, £60 million (US $63.60 million) has been allocated to facilitate the expansion of life sciences manufacturing in the UK. Thus, government initiatives in healthcare research and development play a pivotal role in propelling the cardiovascular and soft tissue repair patches market.

A significant trend gaining traction in the cardiovascular and soft tissue repair patches market is the integration of technological advancements. Companies operating in this sector are actively engaged in developing innovative products and technologies to meet growing market demands. In October 2022, Dozee, an India-based healthcare technology company, introduced an AI-based ECG patch designed for remote cardiac monitoring. This ECG patch, characterized by its small, flexible, and lightweight design, provides a convenient solution for physicians to remotely receive alerts and access live and continuous ECG data from patients. The incorporation of such technological advancements contributes to the overall growth and relevance of the cardiovascular and soft tissue repair patches market.

Leading companies in the cardiovascular and soft tissue repair patches market are actively engaged in developing innovative products, including single-use heart patches, to drive market revenues. The single-use heart patch is an adhesive medical device designed to be directly applied to the heart, providing mechanical support and reducing the stretching of the heart muscle. In October 2022, Mawi, a prominent US-based medical device company, introduced the Mawi Heart Patch-a single-use, two-lead cardiac monitor capable of real-time heart health tracking. This innovative patch offers flexibility in application, allowing for in-clinic or at-home use, and can be worn by patients for up to seven days. The Mawi Heart Patch represents a significant advancement in cardiac monitoring technology, with the potential to enhance patient outcomes and contribute to saving lives.

In June 2024, Stryker, a US-based manufacturer of medical equipment, acquired Artelon for an undisclosed sum. This acquisition is intended to expand its product portfolio in joint preservation and soft tissue reconstruction. Artelon focuses on developing innovative biomaterials for soft tissue reinforcement and repair, especially in the areas of sports medicine and extremities procedures. Artelon is based in Georgia and specializes in medical equipment manufacturing.

Major companies operating in the cardiovascular and soft tissue repair patches market include B Braun, Baxter International Inc., CorMatrix Cardiovascular Inc., Cryolife Inc., Edwards Lifesciences Corporation, LeMaitre Vascular Inc., Anteris Technologies Limited, Abbott Laboratories, Terumo Medical Corporation, Integra LifeSciences Corporation, W. L. Gore & Associates Inc., Arthrex Inc., Johnson & Johnson, Stryker Corporation, LifeCell Corporation, Medtronic Inc., ACell Inc., Tissue Regenix Group Plc, Aroa Biosurgery Ltd., Zimmer Biomet, LifeNet Health Inc., Becton Dickinson and Company, Boston Scientific Corporation, Cook Medical, Endologix Inc., Getinge AB, Vascular Solutions Inc., AngioDynamics Inc., Merit Medical Systems Inc., Penumbra Inc., Glycar SA Pty Ltd., Biointegral Surgical Inc., Admedus Ltd., LabCor Corp., Smith & Nephew plc, Organogenesis Inc.

North America was the largest region in the cardiovascular and soft tissue repair patches market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular and soft tissue repair patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cardiovascular and soft tissue repair patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The cardiovascular and soft tissue repair patches market consists of sales of xenogeneic patch and allogeneic patch. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular And Soft Tissue Repair Patches Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiovascular and soft tissue repair patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiovascular and soft tissue repair patches ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular and soft tissue repair patches market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Raw Materials: ePTFE; Biomaterial And Tissue-Engineered Material; Other Raw Materials
• 2) By Product: Synthetic Patch; Biologic Patch
• 3) By Application: Cardiac Repair; Atrial Septal Defect; Common Atrium; Defects Of The Endocardial Cushion; Ventricular Septal Defect; Tetralogy Of Fallot; Right Ventricular Outflow Tract Reconstruction; Suture Bleeding; Vascular Repair And Reconstruction; Transposition Of The Great Vessels
• 4) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
• Subsegments:
• 1) By ePTFE (Expanded Polytetrafluoroethylene): Non-Absorbable ePTFE Patches; Absorbable ePTFE Patches
• 2) By Biomaterial and Tissue-Engineered Material: Collagen-Based Patches; Synthetic Polymer-Based Patches (e.g., Polypropylene, Polyurethane); Decellularized Tissue Patches
• 3) By Other Raw Materials: Silicones; Hydrogel-Based Materials; Natural Materials
• Companies Mentioned: B Braun; Baxter International Inc.; CorMatrix Cardiovascular Inc.; Cryolife Inc.; Edwards Lifesciences Corporation; LeMaitre Vascular Inc.; Anteris Technologies Limited; Abbott Laboratories; Terumo Medical Corporation; Integra LifeSciences Corporation; W. L. Gore & Associates Inc.; Arthrex Inc.; Johnson & Johnson; Stryker Corporation; LifeCell Corporation; Medtronic Inc.; ACell Inc.; Tissue Regenix Group Plc; Aroa Biosurgery Ltd.; Zimmer Biomet; LifeNet Health Inc.; Becton Dickinson and Company; Boston Scientific Corporation; Cook Medical; Endologix Inc.; Getinge AB; Vascular Solutions Inc.; AngioDynamics Inc.; Merit Medical Systems Inc.; Penumbra Inc.; Glycar SA Pty Ltd.; Biointegral Surgical Inc.; Admedus Ltd.; LabCor Corp.; Smith & Nephew plc; Organogenesis Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiovascular And Soft Tissue Repair Patches Market Characteristics

3. Cardiovascular And Soft Tissue Repair Patches Market Trends And Strategies

4. Cardiovascular And Soft Tissue Repair Patches Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiovascular And Soft Tissue Repair Patches Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiovascular And Soft Tissue Repair Patches PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiovascular And Soft Tissue Repair Patches Market Growth Rate Analysis
• 5.4. Global Cardiovascular And Soft Tissue Repair Patches Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiovascular And Soft Tissue Repair Patches Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiovascular And Soft Tissue Repair Patches Total Addressable Market (TAM)

6. Cardiovascular And Soft Tissue Repair Patches Market Segmentation

• 6.1. Global Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ePTFE
• Biomaterial And Tissue-Engineered Material
• Other Raw Materials
• 6.2. Global Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Patch
• Biologic Patch
• 6.3. Global Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Repair
• Atrial Septal Defect
• Common Atrium
• Defects Of The Endocardial Cushion
• Ventricular Septal Defect
• Tetralogy Of Fallot
• Right Ventricular Outflow Tract Reconstruction
• Suture Bleeding
• Vascular Repair And Reconstruction
• Transposition Of The Great Vessels
• 6.4. Global Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• 6.5. Global Cardiovascular And Soft Tissue Repair Patches Market, Sub-Segmentation Of ePTFE (Expanded Polytetrafluoroethylene), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Absorbable ePTFE Patches
• Absorbable ePTFE Patches
• 6.6. Global Cardiovascular And Soft Tissue Repair Patches Market, Sub-Segmentation Of By Biomaterial and Tissue-Engineered Material, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Collagen-Based Patches
• Synthetic Polymer-Based Patches (e.g., Polypropylene, Polyurethane)
• Decellularized Tissue Patches
• 6.7. Global Cardiovascular And Soft Tissue Repair Patches Market, Sub-Segmentation Of Other Raw Materials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Silicones
• Hydrogel-Based Materials
• Natural Materials

7. Cardiovascular And Soft Tissue Repair Patches Market Regional And Country Analysis

• 7.1. Global Cardiovascular And Soft Tissue Repair Patches Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiovascular And Soft Tissue Repair Patches Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market

• 8.1. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiovascular And Soft Tissue Repair Patches Market

• 9.1. China Cardiovascular And Soft Tissue Repair Patches Market Overview
• 9.2. China Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiovascular And Soft Tissue Repair Patches Market

• 10.1. India Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiovascular And Soft Tissue Repair Patches Market

• 11.1. Japan Cardiovascular And Soft Tissue Repair Patches Market Overview
• 11.2. Japan Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiovascular And Soft Tissue Repair Patches Market

• 12.1. Australia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiovascular And Soft Tissue Repair Patches Market

• 13.1. Indonesia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiovascular And Soft Tissue Repair Patches Market

• 14.1. South Korea Cardiovascular And Soft Tissue Repair Patches Market Overview
• 14.2. South Korea Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiovascular And Soft Tissue Repair Patches Market

• 15.1. Western Europe Cardiovascular And Soft Tissue Repair Patches Market Overview
• 15.2. Western Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiovascular And Soft Tissue Repair Patches Market

• 16.1. UK Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiovascular And Soft Tissue Repair Patches Market

• 17.1. Germany Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiovascular And Soft Tissue Repair Patches Market

• 18.1. France Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiovascular And Soft Tissue Repair Patches Market

• 19.1. Italy Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiovascular And Soft Tissue Repair Patches Market

• 20.1. Spain Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market

• 21.1. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market Overview
• 21.2. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiovascular And Soft Tissue Repair Patches Market

• 22.1. Russia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiovascular And Soft Tissue Repair Patches Market

• 23.1. North America Cardiovascular And Soft Tissue Repair Patches Market Overview
• 23.2. North America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiovascular And Soft Tissue Repair Patches Market

• 24.1. USA Cardiovascular And Soft Tissue Repair Patches Market Overview
• 24.2. USA Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiovascular And Soft Tissue Repair Patches Market

• 25.1. Canada Cardiovascular And Soft Tissue Repair Patches Market Overview
• 25.2. Canada Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiovascular And Soft Tissue Repair Patches Market

• 26.1. South America Cardiovascular And Soft Tissue Repair Patches Market Overview
• 26.2. South America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiovascular And Soft Tissue Repair Patches Market

• 27.1. Brazil Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiovascular And Soft Tissue Repair Patches Market

• 28.1. Middle East Cardiovascular And Soft Tissue Repair Patches Market Overview
• 28.2. Middle East Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiovascular And Soft Tissue Repair Patches Market

• 29.1. Africa Cardiovascular And Soft Tissue Repair Patches Market Overview
• 29.2. Africa Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Raw Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiovascular And Soft Tissue Repair Patches Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiovascular And Soft Tissue Repair Patches Market Competitive Landscape And Company Profiles

• 30.1. Cardiovascular And Soft Tissue Repair Patches Market Competitive Landscape
• 30.2. Cardiovascular And Soft Tissue Repair Patches Market Company Profiles
  • 30.2.1. B Braun Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. CorMatrix Cardiovascular Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Cryolife Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiovascular And Soft Tissue Repair Patches Market Other Major And Innovative Companies

• 31.1. LeMaitre Vascular Inc.
• 31.2. Anteris Technologies Limited
• 31.3. Abbott Laboratories
• 31.4. Terumo Medical Corporation
• 31.5. Integra LifeSciences Corporation
• 31.6. W. L. Gore & Associates Inc.
• 31.7. Arthrex Inc.
• 31.8. Johnson & Johnson
• 31.9. Stryker Corporation
• 31.10. LifeCell Corporation
• 31.11. Medtronic Inc.
• 31.12. ACell Inc.
• 31.13. Tissue Regenix Group Plc
• 31.14. Aroa Biosurgery Ltd.
• 31.15. Zimmer Biomet

32. Global Cardiovascular And Soft Tissue Repair Patches Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiovascular And Soft Tissue Repair Patches Market

34. Recent Developments In The Cardiovascular And Soft Tissue Repair Patches Market

35. Cardiovascular And Soft Tissue Repair Patches Market High Potential Countries, Segments and Strategies

• 35.1 Cardiovascular And Soft Tissue Repair Patches Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiovascular And Soft Tissue Repair Patches Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiovascular And Soft Tissue Repair Patches Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer